🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Citicoline is a safe drug approved in some countries for the treatment of a...
Status
Terminated
Location
Klinikum AltenburgerLand GmbH
Start Date
2006-10
Trial ID
NCT00331890
Treatments Being Tested
the general purpose of the study is to evaluate the potential beneficial ef...
Status
Terminated
Location
Dario Sisto
Start Date
2018-01-25
Trial ID
NCT04422743
Treatments Being Tested
In the period from June 2021 to June 2022, a prospective clinical study wil...
Status
Unknown
Location
Multiple Locations
Start Date
2021-06
Trial ID
NCT04802785
The goal of this observational study is to learn whether a brain-computer i...
Status
Completed
Location
Uludag University
Start Date
2025-02-01
Trial ID
NCT07333339
Treatments Being Tested
Trial Title：The treatment of Vinpocetine（Cavinton）in patients with cerebral...
Status
Completed
Location
Weiwei Zhang
Start Date
2010-05
Trial ID
NCT01400035
The purpose of this study is to determine whether an investigational drug, ...
Status
Completed
Location
University of Pittsburgh, Department of Physical Medicine & Rehabilitation
Start Date
2009-03
Trial ID
NCT00727246
Treatments Being Tested
To evaluate the efficacy of citicoline eye drops 2% in reducing visual fiel...
Status
Recruiting
Location
Presidio Ospedale San Paolo
Start Date
2023-12-11
Trial ID
NCT05710198
Treatments Being Tested
Cognizin is a patented form of citicoline, a natural compound of the brain ...
Status
Completed
Location
Apex Trials
Start Date
2024-11-20
Trial ID
NCT06906848
This randomized study aims at comparing between the effects of amantadine, ...
Status
Completed
Location
Ain Shams University hospitals
Start Date
2017-12-07
Trial ID
NCT03430817
Treatments Being Tested
This study is looking at changes in vision and visual function before and a...
Status
Terminated
Location
Wills Eye Hospital, Glaucoma Research Center
Start Date
2021-02-01
Trial ID
NCT04784234
Treatments Being Tested